Improved monitoring of differences in serial laboratory results

Clinical Chemistry

Volumn 57, Issue 12, 2011, Pages 1635-1637

  Fraser, Callum G ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL PROTEIN; PROTEIN; TROPONIN; UNCLASSIFIED DRUG;

CONCENTRATION (PARAMETERS); EDITORIAL; GAMMOPATHY; HUMAN; LABORATORY DIAGNOSIS; MONITORING; PRACTICE GUIDELINE; REFERENCE CHANGE VALUE; REFERENCE VALUE; SEMANTICS; SPIKE;

HUMANS; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; IMMUNOGLOBULINS; PARAPROTEINEMIAS;

EID: 82755167827     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2011.175026     Document Type: Editorial

References (14)

1. Fraser CG. Inherent biological variation and reference values. Clin Chem Lab Med 2004;42:758-64. (Pubitemid 39137225)
2. Fraser CG. Reference change values: the way forward in monitoring. Ann Clin Biochem 2009;46:264-5.
3. Katzmann JA, Snyder MR, Rajkumar SV, Kyle RA, Therneau TM, Benson JT, Dispenzieri A. Long-term biologic variation of serum protein electrophoresis M-spike, urine M-spike, and monoclonal serum free light chain quantification: implications for monitoring monoclonal gammopathies. Clin Chem 2011;57:1687-92.
4. Durie BG, Harousseau JL, Miguel JS, Blade J, Barlogie B, Anderson K, et al. International uniform response criteria for multiple myeloma. Leukemia 2006;20:1467-73. (Pubitemid 44264086)
5. Smith A, Wisloff F, Samson D, on behalf of the UK Myeloma Forum, Nordic Myeloma Study Group and British Committee for Standards in Haematology. Guidelines on the diagnosis and management of multiple myeloma 2005. Br J Haematol 2006;132:410-51.
6. Fraser CG. Interpretation of differences in serial troponin results. Westgard QC. http://www.westgard.com/troponin-interpretations.htm (Accessed September 2011).
7. Fraser CG. Biological variation: from principles to practice. Washington, DC: AACC Press; 2010.
8. Ricós C, García-Lario J-V, Alvares V, Cava F, Domenech M, Hernández A, et al. Biological variation database, and quality specifications for imprecision, bias and total error (desirable and minimum). The 2010 update. Westgard QC. http://www.westgard.com/biodatabase-2010-update. htm (Accessed September 2011).
9. Ricós C, Iglesias N, García-Lario J-V, Simón M, Cava F, Hernández A, et al. Within-subject biological variation in disease: collated data and clinical consequences. Ann Clin Biochem 2007:44:343-52. See http://www.westgard.com/biological-variation-in-patients-with-disease.htm (Accessed September 2011).
10. Cooper G, DeJonge N, Ehrmeyer S, Yundt-Pacheco J, Jansen R, Ricós C, Plebani M. Collective opinion paper on findings of the 2010 convocation of experts on laboratory quality. Clin Chem Lab Med 2011;49:793-802.
11. Desmeules P, Cousineau J, Allard P. Biological variation of glycated haemoglobin in a paediatric population and its application to calculation of significant change between results. Ann Clin Biochem 2010;47:35-8.
12. Cembrowski GS, Tran DV, Higgins TN. The use of serial patient blood gas, electrolyte and glucose results to derive biologic variation: a new tool to assess the acceptability of intensive care unit testing. Clin Chem Lab Med 2010;48:1447-54.
13. Fraser CG, Harris EK. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989;27:409-37.
14. Cheuvront SN, Fraser CG, Kenefick RW, Ely BR, Sawka MN. Reference change values for monitoring dehydration. Clin Chem Lab Med 2011;49:1033-7.